CI Platform
Sign in
Supernus, Inc.SUPNNYSE NAS ASE DUS FRA LON MXK BLN
Current ReportFundamental Reports

North America / UNITED STATES

Report Sections1

Available for this company

Reporting UnitMillions

NYSE NAS ASE DUS FRA LON MXK BLN

To continue to view the full report

Buy this company's report, or subscribe to a plan.

Already bought this report? Sign in and download it from Order History on your account page; purchased reports are available for 7 days.

Buy ReportSubscribe PlansAlready a member? Sign in

Company Overview

Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company was founded on December 23, 2014 and is headquartered in North Chesterfield, VA.

Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company was founded on December 23, 2014 and is headquartered in North Chesterfield, VA.

Includes quarterly earnings and dividends.

Company Details

Major IndustryPharmaceuticals & Biotechnology
Sub IndustryPharmaceutical Preparations
CountryUNITED STATES
Employees838
Reporting UnitMillions
Primary ExchangeNYSE NAS ASE DUS FRA LON MXK BLN
Instrument TypeEquity
Websiteindivior.com
Wright IDC840NS30T

Key Metrics

Current price$36.28
Market cap$4.53 B
P/E ratio10.04
52-week perf.+23.5%
Common shares124.8 M
Closely held7.7 M
Share typeOrdinary
Quality ratingBBD13
Dividend yield0.00%

Recent stock performance

1 Week+2.6%
4 Week+1.6%
13 Week-9.3%

Officers

n/a

Address

234 BATH ROAD

SLOUGH, BERKSHIRE

UNITED STATES

SL1 4EE

Phonen/a

Quarterly Earnings & Dividends

Quarterly earnings and dividend history is not available for this company.

Try another report for annual statements, Wright Quality history or comparative analysis.